-fenacin
Drugs that block muscarinic receptors, often for overactive bladder.
- Drugs ending in -fenacin: 7
- Approved somewhere: 3
- With a US drug page: 3
- Stem
- -fenacin
- Class
- Drugs that block muscarinic receptors, often for overactive bladder
- Most common targets
- CHRM3 (5), CHRM2 (2), Muscarinic acetylcholine receptor (1), SCN10A (1), SCN11A (1)
Approved and clinical-stage drugs in ChEMBL whose names ending in -fenacin, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Darifenacin | Approved | CHRM3, CHRM2 | Muscarinic acetylcholine receptor M3 antagonist |
| Revefenacin | Approved | CHRM3 | Muscarinic acetylcholine receptor M3 antagonist |
| Solifenacin | Approved | CHRM3, CHRM2 | Muscarinic acetylcholine receptor M3 antagonist |
| Imidafenacin | Phase 3 | CHRM3 | Muscarinic acetylcholine receptor M3 antagonist |
| Afacifenacin | Phase 2 | Muscarinic acetylcholine receptor, SCN10A, SCN11A | Muscarinic acetylcholine receptor antagonist |
| Tarafenacin | Phase 2 | CHRM3 | Muscarinic acetylcholine receptor M3 antagonist |
| Velufenacin | Phase 1 | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO